Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00416533What this trial is testingDocetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forProstate Cancer Wake Forest University Health Sciences 47
Testing effectiveness (Phase 2)Study completedNCT00311623What this trial is testingSirolimus Before Surgery in Treating Patients With Advanced Localized Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)UnknownNCT00005960What this trial is testingCombination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forPainProstate Cancer Amgen
Not applicableLooking for participantsNCT06325046What this trial is testingAdaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate CancerWho this might be right forLocalized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more Mayo Clinic 164
Testing effectiveness (Phase 2)Ended earlyNCT00814892What this trial is testingVaccine Therapy in Treating Patients With Non-Metastatic Prostate CancerWho this might be right forProstate Cancer Mayo Clinic 2
Large-scale testing (Phase 3)Study completedNCT00002855What this trial is testingChemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 306
Large-scale testing (Phase 3)Active Not RecruitingNCT01230866What this trial is testingStudy of Hypo-fractionated Proton Radiation for Low Risk Prostate CancerWho this might be right forProstate Cancer Proton Collaborative Group 150
Not applicableStudy completedNCT00003045What this trial is testingHyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate CancerWho this might be right forProstate Cancer Dana-Farber Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT00078910What this trial is testingNeoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 130
Early research (Phase 1)Study completedNCT00099086What this trial is testingDocetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 20
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00003124What this trial is testingHormone Therapy Plus Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Herbert Irving Comprehensive Cancer Center 105
Large-scale testing (Phase 3)Looking for participantsNCT05946213What this trial is testingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8 NRG Oncology 1,209
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284What this trial is testingAndrogen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma Rutgers, The State University of New Jersey 90
Testing effectiveness (Phase 2)Study completedNCT01243385What this trial is testingMetformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerWho this might be right forProstate Cancer Swiss Cancer Institute 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone SurgeryWho this might be right forPSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more Jonsson Comprehensive Cancer Center 92
Large-scale testing (Phase 3)Study completedNCT00002760What this trial is testingAntiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 260
Large-scale testing (Phase 3)Active Not RecruitingNCT04513717What this trial is testingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialWho this might be right forProstate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8 NRG Oncology 2,753
Large-scale testing (Phase 3)Study completedNCT00062309What this trial is testingComparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate CancerWho this might be right forProstate Cancer Fox Chase Cancer Center 307